Oral Doxycycline for COVID-19 patients
Not Applicable
- Conditions
- Health Condition 1: B342- Coronavirus infection, unspecifiedHealth Condition 2: B342- Coronavirus infection, unspecifiedHealth Condition 3: B338- Other specified viral diseases
- Registration Number
- CTRI/2021/05/033867
- Lead Sponsor
- You Breathe We Care
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Able to give informed consent • Male or female, age 40to 90 years • Typical symptoms of COVUD-19 infection: new onset of or exacerbation of cough due to chronic respiratory illness, dyspnea, Increased body temperature (forehead T° >37.6°C; oral T° >38°C; axillary >37.5°C) • SARS-CoV-2 infection demonstrated by PCR • Admission to hospital within 10 days of onset of symptoms
Exclusion Criteria
Hypersensitivity to doxycycline; myasthenia gravis; pregnancy; hepatic failure (CHILD-Pugh score C); unable to give informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method